Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain-containing protein 83 (WDR83) is a member of the WD-40 protein family functioning as a molecular scaffold for a variety of multimeric protein complexes[1][2][7]. WDR83 is involved in organizing the extracellular signal-regulated kinase (ERK) signaling pathway, acting as a module to mediate and fine-tune ERK responses to different upstream signals. WDR83 also interacts with EGLN3/PHD3, modulating expression levels of hypoxia-inducible factor 1 (HIF-1) and linking hypoxic regulation with cell signaling and apoptosis. Additionally, WDR83 is implicated in RNA splicing and the formation of tight junctions by coordinating cellular polarity. Recent evidence suggests that WDR83 acts as a negative regulator of mTORC1 signaling in nutrient-rich conditions, thereby modulating cellular autophagy[2][7]. WDR83 is not a classic receptor, enzyme, or transporter, but rather a scaffold/adaptor protein involved in signal transduction and the organization of protein complexes, without current evidence supporting direct clinical drug targeting or use as a therapeutic biomarker[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain-containing protein 83 (WDR83).